TP53 and leiomyosarcoma: (2) TP53 inactivation: studies have shown that TP53 mutations or deletions are common in undifferentiated pleomorphic sarcoma (UPS) (18, 19), leiomyosarcoma (LMS) (19, 20), and osteosarcoma (21).